LPL Financial’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.91M | Sell |
146,259
-61,390
| -30% | -$3.42M | ﹤0.01% | 2204 |
|
|
2025
Q4 | $11.6M | Buy |
207,649
+24,252
| +13% | +$1.26M | ﹤0.01% | 1796 |
|
|
2025
Q3 | $8.79M | Buy |
183,397
+71,722
| +64% | +$3.21M | ﹤0.01% | 1988 |
|
|
2025
Q2 | $4.53M | Buy |
111,675
+1,474
| +1% | +$59.3K | ﹤0.01% | 2398 |
|
|
2025
Q1 | $4.83M | Sell |
110,201
-18,194
| -14% | -$803K | ﹤0.01% | 2175 |
|
|
2024
Q4 | $5.52M | Buy |
128,395
+16,227
| +14% | +$738K | ﹤0.01% | 2004 |
|
|
2024
Q3 | $4.98M | Sell |
112,168
-1,553
| -1% | -$66.5K | ﹤0.01% | 1995 |
|
|
2024
Q2 | $4.52M | Sell |
113,721
-51,056
| -31% | -$2.07M | ﹤0.01% | 1943 |
|
|
2024
Q1 | $7.11M | Buy |
164,777
+51,801
| +46% | +$2.23M | ﹤0.01% | 1550 |
|
|
2023
Q4 | $4.7M | Sell |
112,976
-11,806
| -9% | -$447K | ﹤0.01% | 1724 |
|
|
2023
Q3 | $4.96M | Buy |
124,782
+26,031
| +26% | +$1.1M | ﹤0.01% | 1599 |
|
|
2023
Q2 | $4.05M | Buy |
98,751
+3,325
| +3% | +$137K | ﹤0.01% | 1709 |
|
|
2023
Q1 | $3.91M | Sell |
95,426
-4,038
| -4% | -$170K | ﹤0.01% | 1661 |
|
|
2022
Q4 | $4.07M | Sell |
99,464
-18,141
| -15% | -$755K | ﹤0.01% | 1584 |
|
|
2022
Q3 | $4.72M | Buy |
117,605
+11,145
| +10% | +$477K | ﹤0.01% | 1423 |
|
|
2022
Q2 | $4.47M | Buy |
106,460
+14,536
| +16% | +$610K | ﹤0.01% | 1486 |
|
|
2022
Q1 | $4.16M | Buy |
91,924
+1,711
| +2% | +$75.2K | ﹤0.01% | 1558 |
|
|
2021
Q4 | $4.16M | Buy |
90,213
+11,463
| +15% | +$543K | ﹤0.01% | 1570 |
|
|
2021
Q3 | $3.74M | Sell |
78,750
-6,275
| -7% | -$312K | ﹤0.01% | 1590 |
|
|
2021
Q2 | $4.4M | Sell |
85,025
-1,982
| -2% | -$99.5K | ﹤0.01% | 1434 |
|
|
2021
Q1 | $4.38M | Buy |
87,007
+6,287
| +8% | +$335K | 0.01% | 1316 |
|
|
2020
Q4 | $4.2M | Buy |
80,720
+8,869
| +12% | +$424K | 0.01% | 1212 |
|
|
2020
Q3 | $3.12M | Buy |
71,851
+2,065
| +3% | +$90.5K | ﹤0.01% | 1201 |
|
|
2020
Q2 | $3M | Buy |
69,786
+26,759
| +62% | +$1.11M | 0.01% | 1136 |
|
|
2020
Q1 | $1.55M | Sell |
43,027
-7,074
| -14% | -$301K | ﹤0.01% | 1341 |
|
|
2019
Q4 | $2.29M | Buy |
50,101
+16
| +0% | +$634 | ﹤0.01% | 1267 |
|
|
2019
Q3 | $1.78M | Buy |
50,085
+1,915
| +4% | +$71.2K | ﹤0.01% | 1339 |
|
|
2019
Q2 | $1.92M | Buy |
48,170
+1,360
| +3% | +$53.5K | ﹤0.01% | 1276 |
|
|
2019
Q1 | $1.95M | Sell |
46,810
-6,722
| -13% | -$273K | ﹤0.01% | 1199 |
|
|
2018
Q4 | $1.96M | Buy |
53,532
+34,732
| +185% | +$1.48M | 0.01% | 1087 |
|
|
2018
Q3 | $913K | Sell |
18,800
-16,802
| -47% | -$796K | ﹤0.01% | 1732 |
|
|
2018
Q2 | $1.53M | Sell |
35,602
-803
| -2% | -$33.7K | ﹤0.01% | 1320 |
|
|
2018
Q1 | $1.52M | Sell |
36,405
-5,543
| -13% | -$242K | ﹤0.01% | 1294 |
|
|
2017
Q4 | $1.82M | Sell |
41,948
-5,490
| -12% | -$233K | 0.01% | 1130 |
|
|
2017
Q3 | $2.02M | Sell |
47,438
-1,611
| -3% | -$68.3K | 0.01% | 989 |
|
|
2017
Q2 | $2.11M | Sell |
49,049
-3,391
| -6% | -$143K | 0.01% | 901 |
|
|
2017
Q1 | $2.18M | Sell |
52,440
-5,102
| -9% | -$208K | 0.01% | 782 |
|
|
2016
Q4 | $2.31M | Buy |
57,542
+15,295
| +36% | +$622K | 0.02% | 729 |
|
|
2016
Q3 | $1.89M | Sell |
42,247
-6,656
| -14% | -$302K | 0.02% | 804 |
|
|
2016
Q2 | $2.1M | Sell |
48,903
-40,100
| -45% | -$1.7M | 0.02% | 743 |
|
|
2016
Q1 | $3.65M | Sell |
89,003
-133,241
| -60% | -$5.64M | 0.01% | 873 |
|
|
2015
Q4 | $11.2M | Buy |
222,244
+76,815
| +53% | +$3.91M | 0.03% | 407 |
|
|
2015
Q3 | $7.23M | Sell |
145,429
-67,677
| -32% | -$4.08M | 0.04% | 356 |
|
|
2015
Q2 | $13.4M | Sell |
213,106
-21,608
| -9% | -$1.35M | 0.07% | 258 |
|
|
2015
Q1 | $14.4M | Buy |
234,714
+23,280
| +11% | +$1.38M | 0.07% | 243 |
|
|
2014
Q4 | $11.4M | Buy |
211,434
+7,996
| +4% | +$437K | 0.06% | 270 |
|
|
2014
Q3 | $10.7M | Sell |
203,438
-8,208
| -4% | -$417K | 0.06% | 266 |
|
|
2014
Q2 | $11M | Sell |
211,646
-57,202
| -21% | -$2.76M | 0.06% | 264 |
|
|
2014
Q1 | $12.6M | Buy |
268,848
+119,354
| +80% | +$5.64M | 0.08% | 232 |
|
|
2013
Q4 | $6.58M | Sell |
149,494
-48,408
| -24% | -$2.02M | 0.04% | 370 |
|
|
2013
Q3 | $7.74M | Buy |
197,902
+104,482
| +112% | +$3.95M | 0.05% | 308 |
|
|
2013
Q2 | $3.29M | Buy |
+93,420
| New | +$3.15M | 0.02% | 517 |
|
Other funds holding XPH
KWM
FCBT
LPL Financial's XPH Position: Q1 2026 in Review
LPL Financial reduced its State Street SPDR S&P Pharmaceuticals ETF (XPH) stake by 30% in Q1 2026, selling an estimated $3.42M and leaving 146,259 shares worth $7.91M. The position accounts for ﹤0.01% of the portfolio, ranked #2204.
LPL Financial first reported a position in XPH in Q2 2013 and has held it in 52 quarters since. The position peaked at $14.4M in Q1 2015. 82 funds tracked by Wall St. Rank hold XPH as of Q1 2026.
- LPL Financial held 146,259 shares of State Street SPDR S&P Pharmaceuticals ETF worth $7.91M as of Q1 2026.
- LPL Financial sold 61,390 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2026, an estimated $3.42M.
- State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #2204 holding.
- LPL Financial first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2013 and has held it in 52 quarters since.
- LPL Financial's State Street SPDR S&P Pharmaceuticals ETF position peaked at $14.4M in Q1 2015.
- 82 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2026.
Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.